VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema
Young‐sup Yoon(Emory University), Douglas W. Losordo(MACOM (United States)), Edwin C. Gravereaux(Center for Vascular Biology Research), Toshinori Murayama(Northwestern University), David G. Jackson(Huazhong Agricultural University), Marianne Kearney(Northwestern University), Rudolf Kirchmair(Innsbruck Medical University), Andrea Wecker(Center for Vascular Biology Research), Tengiz Tkebuchava(Boston University), Hajime Kubo(University of Helsinki), Marcy Silver(Center for Vascular Biology Research), Jeffrey M. Isner(St. Elizabeth's Medical Center), Cynthia J. Curry(Baylor College of Medicine), Alan B. Ashare(Tufts University), Chunsong Hu(Nanchang University)
Cited by 24
Related Papers
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
|Journal of Clinical Investigation|1998|1.2k
Gene Therapy for Myocardial Angiogenesis
|Circulation|1998|993
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
|Journal of Clinical Investigation|1999|770
Intramyocardial Transplantation of Autologous CD34 <sup>+</sup> Stem Cells for Intractable Angina
|Circulation|2007|557
Diagnostic criteria for Walker‐Warburg syndrome
|American Journal of Medical Genetics|1989|448